Please ensure Javascript is enabled for purposes of website accessibility

Teladoc Stock Rocks to an All-Time High

By Eric Volkman – Updated Jul 7, 2020 at 12:45PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The telehealth services provider remains an "it" stock amid the COVID-19 pandemic.

Teladoc (TDOC 8.23%) is making a serious run at being the most successful coronavirus stock of the pandemic. The telehealth company's shares hit a new all-time high on Friday, before retreating slightly to close a few dollars shy of that level.

The company is the leading provider of remote healthcare services, and those remain a necessity even though many states are starting to reopen their economies and relax their social-distancing mandates. For obvious reasons, most doctors are more cautious about easing up on the measures that were implemented to fight the public health crisis, so services like Teladoc's continue to be much in demand.

Patient using a smartphone for a remote doctor appointment.

Image source: Teladoc.

Teladoc's first-quarter earnings, announced in late April, clearly illustrate this. Revenue rose 41% on a year-over-year basis to nearly $181 million. That well exceeded even the rosiest expectations management set when announcing their guidance (although the outcome wasn't a surprise to the market when it arrives, as the company later announced preliminary results that were close to the final figures).

Encouragingly for its business, Teladoc saw a particularly high jump in total visit fees, which nearly doubled to just under $44 million (the company's revenue consists of subscription fees, still the meat of its business, and visit fees).

Although this hot company's revenues are growing at a torrid pace, investors should be aware that not all is rosy here. Teladoc is still well in the red -- in Q1, its bottom line deficit narrowed -- but not by much -- to $29.6 million. And the company expects to book a net loss both in the current quarter and for the entirety of 2020.

Still, that new record high stock price shows that Teladoc still has a lot of believers. On Friday, even after slipping down from its peak, its shares ended the day up by nearly 5%, in contrast to the broader market, which fell fractionally.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Teladoc Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
$28.00 (8.23%) $2.13

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/04/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.